Skip to content
Screener

CareDx CDNA Q2 2025 earnings

Reported August 6, 2025 · After market close

Revenue$86.7MMiss by $8.6M
EPS$0.10Miss by $0.02
Revenue estimate$95.3M
EPS estimate$0.12

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$121.9M
EPS estimate$0.24

Financials

Q2 2025

Income statement

See full
Revenue$86.7M-6.1%
Operating income-$11.1M-51.8%
Net income-$8.6M-85.3%
EPS (diluted)-$0.16-77.8%

Balance sheet

See full
Cash & equivalents$68.8M-28.6%
Total debt$29.1M-7.4%
Total equity$327.4M+23.7%
Total assets$444.3M-4.8%

Cash flow

See full
Operating cash flow$9.9M-47.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.05B+29.7%
Enterprise value$1.01B+35.7%
P/E18.1×—
P/S3.1×+0.4×

Profitability

See full
Operating margin13.5%+7.4pp
Net margin17.1%+9.7pp

Returns & leverage

See full
Return on equity19.6%+11.4pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.8×

Segments

By product

See full
Testing services revenue$62.0M—
Patient and digital solutions revenue$12.8M—

By segment

See full
Reportable Segment$86.7M-6.1%

FAQ

When did CareDx report Q2 2025 earnings?
CareDx (CDNA) reported Q2 2025 earnings on August 6, 2025 after market close.
What were CareDx's Q2 2025 revenue and EPS?
CareDx reported revenue of $86.7M and eps of $0.10 for Q2 2025.
Did CareDx beat estimates in Q2 2025?
Revenue missed the consensus estimate of $95.3M by $8.6M. EPS missed the consensus estimate of $0.12 by $0.02.
How did CareDx's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 6.1% from $92.3M a year earlier and eps declined 60.0% from $0.25.
Where can I find CareDx's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001217234-25-000045) and the 10-Q periodic report (0001217234-25-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.